The Company will use proceeds to further innovate and accelerate its client offerings, and to sponsor future additional acquisitions.

MIAMI, May 8, 2025 — Diatonic Healthcare (“Diatonic”), a middle market private equity firm focused on healthcare technology and tech-enabled services, today announced a growth investment in Quantix Consulting (“Quantix”), a healthcare and regulated industry specialist staffing platform.

Headquartered in Denver, Quantix has proven itself over the last 23 years as a premier regulated industry and healthcare Cyber & IT staffing company for blue chip enterprise customers. Quantix has become a go-to source for talent and resources for enterprises across healthcare systems, fintech, government, and other regulated spaces. Speed to fill, quality of talent, and unending commitment to customer service has led to Quantix’s tenured relationship with its customers and stellar market reputation. Quantix is committed to helping ensure enterprises are ready for the new wave of cyber hacks, IT challenges, and innovation.

Quantix is led by Michael Haase, an experienced founder and US Air Force veteran, who has dedicated his career to protecting sensitive data and information of large enterprises. For over 25 years, Michael has been a tech enthusiast and entrepreneur. Michael has built, transformed and led organizations in the software, hardware, SAP, and Cloud services spaces. Michael has successfully impacted organizations across many verticals and markets while holding executive roles, fulfilling board positions, and spearheading operations.

“We are thrilled to be making a majority investment into Quantix,” said Maximilien Weiss, Chief Executive Officer of Diatonic. “We have the highest level of conviction that Quantix will further one of Diatonic’s core focus areas: Safeguarding Data, Systems, and Privacy. The United States is facing unprecedented need for IT and Cyber professionals, and companies like Quantix are on the frontline helping meet the demand.”

Michael Haase, CEO and Owner of Quantix, added “We’re thrilled at Quantix to take this next step in our journey with this strategic acquisition and growth investment. Our partnership with Diatonic will accelerate our growth trajectory, unlock new market opportunities, and enhance our ability to deliver world class service to our customers and consultants at scale. We are facing a surging domestic demand for Cyber and IT services, and Diatonic is the perfect partner to help us capture the opportunity.”

Diatonic received legal counsel from Greenberg Traurig LLP, and Financial & Tax Consulting work from Withum Smith+Brown, PC.

About Quantix
Quantix is an IT workforce management services provider that prioritizes people and purpose for growth, pioneering the road map for changing the culture in the IT services industry. For 23 years Quantix has connected highly talented, inspired individuals with dynamic teams and leaders across the United States. Dually focused on client success and employee career potential, Quantix is built on a foundation of a human-centered yet tech-enabled approach that builds deep, trusted relationships. Linked by shared values and a commitment to process, the Quantix team confidently and consistently delivers the intangible, unique recipes created in connecting employers and talent. Visit www.quantixinc.com.

About Diatonic Healthcare
Diatonic Healthcare, LLC (“Diatonic”) is a Miami-based private equity company focused on investing into healthcare technology and tech-enabled services. Diatonic brings a founder-friendly approach along with deeply thematic sourcing and portfolio operational support. Since inception, Diatonic has carved out a niche in healthcare and regulated IT & Cyber investing across its portfolio companies. Targeted stages of investment include growth equity through control buyouts. Diatonic’s deal sizes range from $10 – $150 million for platform investments. Visit www.diatonichealthcare.com.

Contact: Maximilien Weiss
Diatonic Healthcare, LLC
786-546-6973
[email protected]

SOURCE Diatonic Healthcare

The strategic backing of CDPQ and Nuveen positions Redaptive to rapidly expand its footprint and leverage its EaaS platform as a growth engine.

DENVER, May 8, 2025 — Redaptive, a leading Energy-as-a-Service (EaaS) provider, today announced the successful closing of a $650 million (CAD 903 million) credit facility from CDPQ, a global investment group, and Nuveen, the investment manager of TIAA. This facility strengthens Redaptive’s ability to scale its innovative platform, meet accelerating customer demand, and deliver measurable business value through energy efficiency, renewable generation, and data-driven building performance.

Redaptive can now expand its investment in physical asset infrastructure across large enterprise portfolios, enabling customers to reduce operating costs, enhance resilience, and meet long-term business growth and sustainability goals — all without the end users’ upfront capital or added operational complexity. Redaptive’s platform combines flexible finance structures, AI-powered insights, and proprietary metering technology to turn energy and infrastructure into a strategic engine of efficiency and performance.

“This new credit facility is a vote of confidence in both our team and our mission,” said Matt Gembrin, CFO of Redaptive. “Enterprises are under increasing pressure to modernize their infrastructure while staying financially agile. Our model continues to prove that you don’t have to choose between operational efficiency, capital discipline, and sustainability — you can achieve all three.”

$650M Credit Facility from CDPQ and Nuveen to Accelerate Energy Optimization Initiatives

Redaptive will leverage this capital to continue its support of enterprise customers with
data-driven efficiency and energy generation programs, including HVAC, LED lighting, solar, storage and metering solutions, and other upgrades that can be deployed at large-scale multi-site portfolios. This additional financing will enable Redaptive to expand its reach, increase project deployments, and further develop its solutions across the U.S., Canada, and certain European jurisdictions.

“Redaptive is a leader in helping their clients adopt energy and power solutions that reduce energy costs and consumption, while changing how industries approach sustainability,” said Don Dimitrievich, Head of Nuveen’s Energy Infrastructure Credit business. “Our investment reflects our confidence in Redaptive’s ability to scale their business, while reducing carbon emissions globally.”

A Strategic Leap Toward Sustainability, Resilience, and Results That Scale

The new facility from CDPQ and Nuveen underscores Redaptive’s ability to drive meaningful progress toward decarbonization while enabling customers to build more resilient and efficient operations. Redaptive continues to set benchmarks in energy efficiency, sustainability innovation, and scalable energy solutions for their customers through their Energy-as-a-Service solution and the Redaptive ONE data platform. With this latest support, Redaptive is poised to accelerate the deployment of its platform across new markets and solution categories, continuing to build momentum as the trusted infrastructure partner for enterprises navigating the energy transition.

“CDPQ and Nuveen are both valued partners in our journey, and we are grateful for their trust in Redaptive’s vision,” said Arvin Vohra, CEO of Redaptive. “This additional support from both global investors allows us to scale our impact, bring our programmatic solutions to more customers, and accelerate the transition to a more sustainable future.”

Recently, Redaptive’s Energy-as-a-Service offering was recognized as a “Top Product of the Year” in the prestigious E+E Leader Product & Project Awards. Judges recognized Redaptive as an outstanding example of innovation in the sustainability and infrastructure sector.

 To learn more, please visit https://redaptive.com/.

About Redaptive
Redaptive is a leading Energy-as-a-Service provider enabling Fortune 500 commercial and industrial enterprises to turn real asset infrastructure into a strategic engine for growth and efficiency—bringing together capital, intelligence, and performance. Founded in 2015 and headquartered in Denver, Colorado, Redaptive funds and deploys energy-saving and energy-generating systems across large, distributed real estate portfolios. Its programs help enterprises reduce energy waste, lower carbon emissions, and optimize operating costs—supporting broader business objectives such as operational resilience, financial performance, and long-term sustainability. Through flexible financing structures, asset performance optimization, and AI-driven intelligence, Redaptive empowers organizations to scale energy-efficient solutions faster and smarter. For more information, visit Redaptive.com.

About Nuveen
Nuveen, the investment manager of TIAA, offers a comprehensive range of outcome-focused investment solutions designed to secure the long-term financial goals of institutional and individual investors. Nuveen has $1.3 trillion in assets under management as of 31 Dec 2024 and operations in over 32 countries. Its investment specialists offer deep expertise across a comprehensive range of traditional and alternative investments through a wide array of vehicles and customized strategies. For more information, please visit www.nuveen.com.

Media Contact
Jimmy Rogers
Redaptive
425-463-9479
[email protected]

SOURCE Redaptive

Latest Financing Will Ramp High-Volume Manufacturing and Accelerate Deployment for Next-Gen Space Missions

ALBUQUERQUE, N.M., May 8, 2025 — mPower Technology, the leading provider of solar power solutions for space, announced it has secured over $21 million in Series B funding led by Razor’s Edge Ventures and joined by Shield Capital. The new funding will be used to further scale production capacity, continue the advancement of DragonSCALES^™ and position the company for sustained leadership in the rapidly expanding commercial and national security space markets. The capital raise builds upon mPower’s Series A financing led by Cottonwood Technology following its spin-off from Sandia National Laboratories.

“mPower has emerged as the only solar provider in the space market with a flight-proven design that can meet both the aggressive cost targets and production volumes required by large-scale Space 2.0 missions, such as LEO constellations,” said Kevin Hell, president and CEO of mPower Technology. “This new funding from highly regarded space sector investors that focus on national security, is a testament to the confidence our customers have in our proven ability to rapidly deliver space power at scale.”

“Space capabilities have been used as an economic engine and to enhance national security for decades. The entire space ecosystem is on the cusp of transformational growth, and nothing happens in space without power. It is a critical enabler,” said Mark Spoto, managing partner of Razor’s Edge. “The confidence we have in mPower is based on real-world proof – its solar solutions are in orbit and delivering value now. It is the only company in the market with proven automated manufacturing that is now ready for high-rate production.”

With a significant new business pipeline and over 12 years of combined on-orbit space heritage, mPower is rapidly becoming the leading provider of power solutions for the next generation of space missions. mPower has been chosen as a solar power provider for key industry players such as Airbus, Blue Origin/Honeybee, Firefly Aerospace, Lynk Global, Gravitics and many others.

This growing roster of customers will be supported by mPower’s first high-volume automated manufacturing line which is located at mPower’s contract manufacturer Universal Instruments Corporation in Conklin, New York. This line dramatically expands throughput and will produce over 2 megawatts of DragonSCALES modules annually, a capacity greater than the total combined global production output of traditional gallium arsenide (III-V) solar module suppliers. High-volume operations commence next month and will produce solar modules for hundreds of spacecraft, including mPower’s contract to supply more than 1.1 megawatts of solar modules for Airbus’ MDA AURORA™ program, one of the largest space solar deals in history.

About mPower Technology, Inc.
mPower Technology is shaping the future of solar power with a revolutionary new technology called DragonSCALES™, a completely flexible, interconnected mesh of miniature solar cells. Leveraging well-established and affordable materials, processes and tools for the silicon PV and microelectronics industries, DragonSCALES enables completely new design options for solar power, removing the constraints of existing silicon and gallium arsenide solar solutions, and enabling highly flexible, resilient, lightweight designs that can be rapidly deployed at extremely low cost. Follow us on LinkedIn, X and Facebook, or visit mpowertech.com for the latest news and information.

About Razor’s Edge
Razor’s Edge is a growth equity firm that invests in technology companies solving significant challenges in national security and high-growth commercial markets. In addition to providing capital to accelerate the pace of innovation, Razor’s Edge offers direct and practical operational support informed by decades of collective experience in the national security sector. The Razor’s Edge team works tirelessly to identify disruptive technologies and capabilities that can solve critical mission needs and deliver them to government and commercial customers who need them. For more information, visit www.razorsvc.com.

Media Contact:
Natalie Rizk
RiotMind
Phone: +1-505-252-4279
Email: [email protected]

SOURCE mPower Technology

Company exits stealth after multi-year enterprise build-out; new capital fuels expansion of ACRA platform usage into public-sector and national defence-related projects

Backers include Scout Ventures, Artis Ventures, and angel investor Gokul Rajaram

Valarian Defence aims to meet rising global demand for secure, compartmentalized systems

LONDON, May 8, 2025 — Valarian, the company behind ACRA — a platform for enforced isolation and compartmentalized infrastructure — today emerged from stealth, announcing $7 million in new strategic funding, bringing its total seed to $20 million.

With rising demand for control-first security postures, this latest capital injection will fund the public launch of Valarian Defence, an offering built specifically for governments and institutions operating in high-risk, mission-critical environments.

The round was co-led by defence-focused Scout Ventures and Artis Ventures, both making rare investments outside the United States, with participation from angel investor Gokul Rajaram. Previous investors have included Molten Ventures, IQ Capital, and MD One.

“Our conviction in Valarian isn’t just about the technology — it’s about what it represents: a next generation of dual-purpose software. Seeing innovation like this coming out of the UK shows how geographically global this problem set is,” said Cody Huggins, partner at Scout Ventures.

Founded by operators with frontline experience, Valarian brings together expertise from military, finance, and systems domains. Max Buchan, a former international finance operator, and Josh McLaughlin, a former U.S. Army officer and Palantir executive, created Valarian’s ACRA platform based on their experiences in environments where trust routinely fails.

After a few years of building and hardening ACRA to accommodate the needs of regulated enterprises, Valarian is now scaling its platform into national security and critical coordination environments where traditional security approaches have proven inadequate.

“We built ACRA because the environments we came from didn’t trust shared infrastructure — and now that skepticism is becoming standard,” said Max Buchan, Valarian’s Co-Founder and CEO. “The more sophisticated the threat landscape becomes, the less room there is for improvisation in how institutions protect communications, data, and operational continuity.”

To date, the company has developed two core product lines: Privileged Communication and External Comms Capture for regulated enterprises, while Valarian Defence extends these capabilities to government-grade deployments requiring enforced compartmentalization and secure coordination infrastructure.

“Breaches don’t just leak sensitive data anymore — they disrupt discretion, decision-making, and the ability to respond,” said Josh McLaughlin, Co-Founder and COO of Valarian. “Valarian Defence is about helping governments and institutions retain control even when everything else is under stress.”

The company will use the new capital to expand its government partnerships, develop additional deployment pathways, and bring platform-level containment to environments previously reliant on retrofitted security measures.

To learn more, visit: www.valarian.com  

About Valarian

Valarian delivers infrastructure for institutions operating at the front lines of risk. Its platform, ACRA, enforces isolation, auditability, and control—designed to contain threats and preserve operational integrity when assumptions about trust fail.

Valarian serves both regulated enterprises and national security programs with compartmentalized systems for secure communication, compliance, and continuity. Its core offerings include Privileged Communication, a tightly permissioned collaboration suite, and External Comms Capture, a tool for monitoring and archiving messaging platforms like WhatsApp, Signal, and Telegram. For government and defence contexts, Valarian Defence extends ACRA’s architecture to environments where discretion, coordination, and jurisdictional control are non-negotiable.

Founded by leaders from the military, financial, and technical domains, Valarian builds with the belief that critical systems deserve architecture—not improvisation.

To learn more, visit: www.valarian.com  

Press Contact

Luca Sesti
[email protected]

SOURCE Valarian

VIENNA, May 7, 2025 — Dr. Werner Lanthaler, Founder and CEO of Wlanholding GmbH, has been appointed Chairman of the Supervisory Board at aTENSION.life, a high-tech life science startup developing precision diagnostics for hypertension. The appointment comes as part of a USD 3 million seed financing round led by Wlanholding, with eQventure and VP Venture Partners as co-lead investors.

aTENSION.life’s proprietary ALDO+ technology platform makes advanced mass spectrometry-based diagnostics accessible to patients with uncontrolled hypertension. The company’s first product, ALDO+PA, screens for primary aldosteronism, a significantly underdiagnosed condition affecting 5-10% of all hypertensive patients.

“Every hypertension patient deserves an early and precise diagnosis leading to a targeted treatment. This funding brings us one step closer in making clinical mass spectrometry diagnostics available to everyone,” states Dr. Lanthaler regarding his appointment at aTENSION.life.

The investment aligns with Dr. Lanthaler’s strategic focus on transformative technologies in the life sciences sector. Through Wlanholding, he continues to identify and support innovative companies addressing significant healthcare challenges. The ALDO+PA test is currently available in Austria through a partnership with labors.at and is planned to roll out across DACH markets by 2026, with first customers already implementing the technology in Germany, Switzerland, and the US.

aTENSION.life’s innovative approach addresses a vast global market, with approximately 1.3 billion adults affected by hypertension and 720 million not receiving adequate treatment due to underdiagnosis of specific hypertension subtypes.

Dr. Lanthaler will provide strategic guidance to aTENSION.life’s newly announced management team: Bernhard Klemen (CEO), Marko Poglitsch (CSO), and Katharina Wieser (CBO).

About Wlanholding GmbH

Wlanholding GmbH is a Family Office focused on investments and advisory services in life science and high-tech driven sustainability companies. Led by Dr. Werner Lanthaler, former CEO of Evotec SE, Wlanholding supports passionate founders and management teams to transform innovative businesses into scalable organizations with global impact. For more information, visit https://wlanholding.com/

About aTENSION.life

aTENSION.life is transforming hypertension care by making advanced mass spectrometry diagnostics accessible to everyone. The company’s ALDO+ technology platform sets new standards in precision diagnostics for hypertension, enabling targeted therapies with just one blood sample. For more information, visit www.atension.life.

Media Contact:

Mag. Katharina Wieser
Wlanholding GmbH
Schönborngasse 4, 1080 Vienna
[email protected], +436769633045
www.wlanholding.com

SOURCE Wlanholding GmbH

Cash subsidy valued at up to 1.22 billion PLN is one of the largest grants ever offered by Poland’s Ministry of Economic Development and Technology

WARSAW, Poland, May 7, 2025 — The Ministry of Economic Development and Technology in Poland today offered Ascend Elements up to USD $320 million to support construction of a sustainable precursor cathode active material (pCAM) manufacturing facility in Poland. pCAM is a high-value, precisely engineered material used in the manufacture of lithium-ion batteries for electric vehicles and other advanced industrial applications. The cash subsidy of 1.22 billion Polish Zloty (PLN) is one of the largest grants ever offered by the Republic of Poland. As part of the E.U.’s Temporary Crisis and Transition Framework (TCTF), the grant is designed to support Europe’s transition to a net-zero economy.

“This offer of support from the Polish government marks a significant step forward in Ascend Elements’ European growth strategy,” said Linh Austin, President and CEO at Ascend Elements. “We are committed to building a sustainable battery materials supply chain on both sides of the Atlantic, and we greatly appreciate the Ministry’s offer of significant financial support.”

Ascend Elements has already identified a location in Poland for the construction of its first advanced battery materials (pCAM) manufacturing facility in Europe. CEO Linh Austin met with Poland’s Secretary of State Michał Jaros at the Polish Ministry of Economic Development and Technology in Warsaw on Wednesday to receive the grant offer.

“Battery sector projects are a key part of PAIH’s investment portfolio,” said Pawel Pudlowski, Ph.D., Vice President of the Management Board at the Polish Investment and Trade Agency (PAIH). “The Ascend Elements project is one of the largest U.S. investments in recent years, strengthening Poland’s role in the battery supply chain and supporting regional development, including technology development and cooperation with local educational institutions.”

Ascend Elements plans to commercialize its innovative technology for the manufacture of sustainable nickel, manganese, and cobalt (NMC) pCAM made from recycled lithium-ion battery materials at the new facility in Poland.

“We are deeply grateful for the support of the Polish government and thrilled to expand our presence in Europe,” said Tomasz Poznar, Ph.D., Senior Vice President of Commercial at Ascend Elements.

Photo – https://mma.prnewswire.com/media/2681603/Ascend_Elements___Linh_Austin_and_Michal_Jaros.jpg

Logo – https://mma.prnewswire.com/media/1930392/Ascend_Elements_Logo.jpg

Additional capital will fuel growth and product expansion to meet increasing demand as startups face a shifting economic landscape

SANTA MONICA, Calif., May 7, 2025 — SimpleClosure, the easiest and most trustworthy way to shut down your startup, today announced it has raised $15 million in fresh funding. Led by TTV Capital, the Series A round is a fast follow from its February 2024 seed round and includes participation from existing investors Infinity Ventures, Anthemis, Vera Equity, and new investors The LegalTech Fund and Carta, as well as additional angels. This new infusion of capital brings SimpleClosure’s total funding to more than $20 million at a time when startups are facing delayed IPOs, stalled M&A, and a potential new wave of shutdowns in an uncertain economy.

“The reality is that 90% of startups don’t make it, and shutting down remains the unspoken but necessary part of entrepreneurship. We hope companies never need us, but if they do, we’re here to help them do it the right way,” said Dori Yona, Founder and CEO of SimpleClosure. “Day in and out, our team builds with care, urgency, and a deep belief in the impact of what we are creating. This funding will help us grow faster, build smarter, and deliver even more value to the founders who rely on SimpleClosure when it matters most.”

Startups, VC-backed companies, and businesses of all sizes are facing mounting pressure from a challenging macroeconomic environment. Global trade tensions and renewed tariffs, coupled with rising interest rates and a greater cost of capital, are forcing founders to stretch their runway or focus on critical cost cutting measures. At the same time, amidst a less-friendly IPO environment, mergers and exits are making investors more cautious. Startups are also grappling with valuation resets after raising at inflated levels during recent boom years. This shift toward efficient growth over rapid scaling leaves companies that cannot quickly demonstrate sustainability to rethink their strategy entirely, which often includes shutting down.

SimpleClosure was founded with a simple but critical mission: to transform the painful and bureaucratic dissolution process so founders can focus on their next project. The company’s technology automates regulatory paperwork, legal filings, compliance, and investor communications, leveraging AI agents to bring order and transparency to an otherwise time-consuming and confusing process. By combining fintech, legal tech, and AI, SimpleClosure resolves any remaining obligations with customers, state agencies, and team members on behalf of the dissolving business. To date, more than 1,500 founders from companies of all sizes have wound down their businesses with SimpleClosure.

Since its public launch in September 2023, SimpleClosure has significantly scaled its operating efficiencies to meet growing demand and built out a world class team combining top R&D talent with legal and dissolution experts. 

The new infusion of capital will support the company’s continued growth, including product updates and integrations, to scale the platform and reach more founders and verticals during a time of heightened need. SimpleClosure was recently named to FastCompany’s Most Innovative Companies 2025 and is a winner of the 2024 LegalTech BreakThrough Awards.

“SimpleClosure quickly proved there is high demand for a platform that streamlines company dissolutions, saving businesses both time and money,” said Lizzie Hartley, partner at TTV Capital. “The company’s strong growth over the past year is a testament to the product that Dori and his team have built — one they wish they had when they were winding down their own startups. We are proud to support the SimpleClosure team as they continue to scale the business and meaningfully address the complexities of shutting down a company.”

About SimpleClosure
SimpleClosure was founded with a simple but critical mission: to make a complicated and confusing shutdown process feel like a manageable reality — the unlock founders were looking for. We handle the paperwork, legal filings, and compliance. This is our sole focus, and we make sure it gets done right. Our team of specialists are dedicated to helping founders fast-track their shutdown, so they can focus on the future. To learn more, please visit www.simpleclosure.com. 

Media Contact:
[email protected]

SOURCE SimpleClosure

Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General Hospital Ventures, Memorial Hermann Health System, Frist Cressey Ventures, Storm Ventures, Paramark Ventures, CU Healthcare Innovation Fund, and Mass General Brigham Ventures

SAN FRANCISCO, May 7, 2025 — Carta Healthcare, a leading provider of AI-powered clinical data abstraction, today announced it has secured $18.25 million in Series B1 financing. This investment will accelerate the company’s growth as demand surges among health systems and life sciences organizations for AI-driven innovation that transforms clinical data into valuable insights.

The investment was led by UPMC Enterprises, with participation from new strategic investors, including MemorialCare Innovation Fund, Rex Health Ventures (the investment fund for the UNC Health), Tampa General Hospital Ventures and support from existing investors Memorial Hermann Health System, Frist Cressey Ventures, Storm Ventures, Paramark Ventures, CU Healthcare Innovation Fund, and Mass General Brigham Ventures.

“UPMC Enterprises invests in companies that are solving real problems in healthcare delivery,” said Brent Burns, executive vice president at UPMC Enterprises, the innovation, commercialization and venture capital arm of UPMC. “Health systems face significant challenges associated with clinical data abstraction and patient trial matching, which are time-consuming, labor-intensive processes. Carta Healthcare leverages AI to streamline data abstraction and provide analytics that clinicians can use to improve patient care. We look forward to partnering with Carta Healthcare to advance their mission and explore opportunities to implement their solutions across our health system.”

The new funding will enable Carta Healthcare to further expand its growing customer footprint, particularly in the life sciences market, following the late 2024 acquisition of Realyze Intelligence from UPMC Enterprises. Realyze Intelligence’s technology leverages AI to rapidly analyze structured and unstructured data and identify specific patients that match clinical trials and other research studies.

“We have long recognized that better clinical data abstraction and activation is integral to improving healthcare,” said Navid Farzad, Managing Partner at Frist Cressey Ventures. “Since our initial investment, Carta has been laser focused on solving this challenge for health systems by using the Carta Healthcare AI platform to automate the data abstraction process, generating high-quality clinical data while simultaneously realizing an immediate ROI by reducing the high labor cost of data abstraction.”

“As a community-focused health system, we’re always looking to invest in new digital technologies that will enable us to better meet the diverse needs of our patients in the Greater Houston area, while also supporting our providers and physician partners,” said Feby Abraham, executive vice president and chief strategy officer for Memorial Hermann Health System. “Our vision is to create healthier communities, now and for generations to come. By partnering with Carta Healthcare, we are investing in a platform that will help us drive innovation and provide the best care possible for our patients.”

Founded in 2017, Carta Healthcare has pioneered innovative approaches to clinical data abstraction and healthcare analytics. The company’s technology combines AI, machine learning, and deep clinical expertise to automate the collection and analysis of clinical data, enabling healthcare organizations to generate actionable insights that drive quality improvement initiatives.

“This significant investment from leading health systems further validates and empowers our mission to harness the power of data, ensuring that care teams and researchers have the information they need, when they need it,” said Carta Healthcare CEO Brent Dover. “With their support and adoption of our solutions, we can continue to expand upon our deep clinical domain expertise, scale our operations and product deployment, and activate their structured and unstructured data as close to real time as possible to support process improvement and quality initiatives.”

Carta Healthcare CFO Lucas Tanner said the latest investment round supports a financially healthy company.

“We’ve demonstrated consistent year-over-year growth by focusing on delivering measurable value to healthcare systems,” he added. “This new capital will allow us to scale our team and infrastructure to meet increasing market demand. With a strengthened balance sheet and critical insights from industry-leading strategic investors, we are well-positioned to capture the significant market opportunity ahead of us.”

For more information about Carta Healthcare and its solutions, visit www.carta.healthcare.

About Carta Healthcare
At Carta Healthcare, we believe that high-quality data is the foundation for better healthcare outcomes. Traditional methods for abstracting data from clinical systems are often labor-intensive, time-consuming, and costly. As the leading provider of clinical data management solutions, Carta Healthcare leverages advanced artificial intelligence and a team of expert clinical professionals to deliver accurate, high-quality, and actionable clinical data that drives healthcare improvements. By streamlining data abstraction, Carta Healthcare significantly reduces costs and enhances operational efficiency for hospitals and health systems. Recognized for its innovation with accolades such as the Merit Award, Pinnacle Award, and BIG Innovation Awards, Carta Healthcare is transforming the future of healthcare data management. Discover more at https://www.carta.healthcare/

Media contact:
Katlyn Nesvold
Amendola Communications for Carta Healthcare
[email protected]

SOURCE Carta Healthcare

Backed by Emerald Development Managers, AgFunder, and MANN+HUMMEL, Uviquity aims to revolutionize air, food, and water disinfection with its chip-scale far-UVC light sources

RALEIGH, N.C., May 7, 2025 — Uviquity, a deep tech startup pioneering next-generation photonic disinfection technologies, today announced it has emerged from stealth with $6.6 million in seed funding. The round was led by Emerald Development Managers, an early-stage venture capital firm specializing in deep tech, with participation from AgFunder and MANN+HUMMEL, global leaders in food and agriculture venture capital and advanced filtration solutions.

Uviquity is developing solid-state far-UVC (200-230 nm) semiconductor light sources designed to deliver safe, continuous, and chemical-free disinfection for air, food, and water applications. The funding will support Uviquity’s research and development efforts, accelerating the productization of its core technology—a proprietary photonic integrated circuit that couples blue laser light into frequency-doubling waveguides, enabling a scalable, single-chip far-UVC solution that can fit on the tip of your finger and seamlessly integrate into a wide variety of applications using standard photonic packages.

“We believe far-UVC light is the future of pathogen control—and Uviquity’s wide-bandgap semiconductor platform is the key to making it practical, scalable, and safe,” said Scott Burroughs, CEO and co-founder of Uviquity. “This funding allows us to bring our vision to life and unlock a new standard for clean air, safe food, and pure water—at scale and without chemicals.”

A Safer, More Effective Way to Disinfect

Unlike conventional UV-C solutions, far-UVC light has been proven safe for continuous exposure to human skin and eyes while rapidly inactivating all known pathogens, including viruses, bacteria, fungi, and mold spores. Until now, far-UVC systems have relied on bulky gas-discharge lamps with limited scalability and reliability.

Uviquity’s chip-based semiconductor approach represents a paradigm shift, offering a compact, energy-efficient, and durable solution that can be integrated into light fixtures, air handling systems, food packaging and processing equipment, agricultural crop protection systems, water purification systems, and consumer appliances.

Broad Applications, Global Impact

Uviquity’s solid-state far-UVC platform opens the door to a wide range of transformative applications:

• Air disinfection in public and private spaces, providing invisible, always-on protection from airborne illnesses
• Pesticide-free crop protection, enabling healthier and more sustainable agriculture
• Chemical-free water purification, delivering clean water at any scale without harmful byproducts

“With its proven team and novel technology, Uviquity fits perfectly with our goal to invest in exceptional companies that are solving real problems,” said Cy Schroeder of Emerald Development Managers. “We believe Uviquity’s semiconductor approach to far-UVC will revolutionize how the world handles disinfection.”

About Uviquity

Founded in 2022 by a team of scientists, engineers, and photonics experts, Uviquity is on a mission to develop and commercialize technology to improve the air we breathe, the food we eat, and the water we drink. By harnessing the power of solid-state far-UVC light, Uviquity enables continuous, safe, and sustainable protection from pathogens across multiple industries.

For more information, visit www.uviquity.com.

SOURCE Uviquity Inc.